Bioreactors and Fermenters Market, By Type (Single-use Bioreactors, and Multiple-use Bioreactors), By Process (Fed batch, Continuous, and Batch), By End User (Biopharmaceutical companies, CROs, and Academic & Research Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

The market for bioreactors and fermenters was valued at US$2.3 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 10.4% to reach US$6.2 billion by 2030.

Fermenters and bioreactors drive biochemically active substances derived from microorganisms or create the ideal environment for their growth. In essence, fermenters are used to maintain and grow a population of fungi or bacteria under controlled conditions. The biopharmaceutical industry uses bioreactors, which are large fermenters, extensively to assemble biologics on a massive scale, such as recombinant proteins, monoclonal antibodies, and vaccines.